RxDoctor Payments DataLook up a doctor →

Jeffrey Loveland, DPM

Podiatrist · Sparta, TNNPI 1306047501

Payments from drug & device makers

$808,671in general payments, 2019–2025

Across 840 payments — averaging $962.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$499K
  • Vilex LLC$286K
  • Tyber Medical, LLC$9K
  • Smith+Nephew$4K
  • Arthrex$3K
  • International Life Sciences$2K
  • plus $5K from 29 others
$17,998in research payments, 2019–2025

Across 9 payments — averaging $1999.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$18K

What the payments were for

  • Royalty or licence$209,60426%
  • Consulting fees$463,59057%
  • Speaking & faculty fees$39,1205%
  • Travel & lodging$64,5178%
  • Food & beverage$17,0922%
  • Education$14,7482%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$808,671 in reported general payments places this provider in the 95th percentile of 105 podiatrist providers in Tennessee.

See all podiatrist providers in Tennessee

Medicare billing

Part B allowed, 2024
$123,287
Medicare patients
339
Services billed
1,558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Vancomycin Hcl17$1,478
Doxycycline Hyclate58$720
Mupirocin87$645
Methylprednisolone69$523
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$324
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen69$322
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim45$309
Levofloxacin60$285
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$196
Ciprofloxacin Hcl12$152
Meloxicam38$147
Fluconazole16$64
Tramadol Hcl11$25

Paid to pharmacies, not to this prescriber.

Other podiatrist in Sparta

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →